Results 131 to 140 of about 4,062 (173)

The three-dimensional perspective of CAR-T cell therapy in autoimmune diseases. [PDF]

EBioMedicine
Shen J, Mao J, Ye Q.
europepmc   +1 more source

Challenges and opportunities: CAR-T cell therapy in autoimmune diseases. [PDF]

Cell Insight
Yan R, Ye S, Xu H.
europepmc   +1 more source

Peripheral nerve block in patients with medication-overuse headache: systematic review and meta-analysis. [PDF]

BMC Neurol
Arias-Tello PA, Coronado-Caceres CF, Serrano-Sablich ME, Mantilla G, Goicochea MT, Alarcon-Ruiz CA.   +5 more
europepmc   +1 more source

Edwin Miller Caar

, 1987
Peninsula Times Tribune
core  

Emerging Cell-Based Therapies for Systemic Sclerosis: From Stem Cells to CAR-T Cells. [PDF]

Curr Issues Mol Biol
Chasov V, Mukhametshin S, Gilyazova E, Davletshin D, Tikhomirova M, Topchu I, Valiullina A, Prete M, Bulatov E.   +8 more
europepmc   +1 more source

Chimeric antigen receptor (CAR) therapies for precise eradication of pathogenic cells in autoimmunity. [PDF]

Arthritis Res Ther
Kalliolias GD, Basdra EK, Papavassiliou AG.   +2 more
europepmc   +1 more source

CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon. [PDF]

Front Immunol
Wu D, Xu-Monette ZY, Zhou J, Yang K, Wang X, Fan Y, Young KH.   +6 more
europepmc   +1 more source

Contemporary review of primary membranous nephropathy. [PDF]

Front Immunol
Filippone EJ, Farber JL.
europepmc   +1 more source

The cascade to pathogenicity in autoantibody-mediated CNS diseases. [PDF]

Brain
Montini F, Wing E, Herman M, Pittock SJ, Lopez Chiriboga S, Flanagan EP, Irani SR.   +6 more
europepmc   +1 more source

Advance in chimeric antigen receptor T therapy in autoimmune diseases. [PDF]

Front Immunol
Ji X, Sun Y, Xie Y, Gao J, Zhang J.
europepmc   +1 more source